🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purposes of this study include 1) to compare the seroconversion rate of...
Status
Unknown
Location
Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University
Start Date
2011-01
Trial ID
NCT01289106
Treatments Being Tested
The purpose of this study is to determine 1. vaccination coverage of recom...
Status
Completed
Location
UZ Leuven
Start Date
2014-10
Trial ID
NCT03820752
MaHeVi is a multicenter, cross-sectional, population-based study which will...
Status
Completed
Location
General Hospital of Cayenne
Start Date
2018-01-01
Trial ID
NCT05002907
Many short- and long-term consequences, including altered physiological par...
Status
Unknown
Location
Kirsehir Ahi Evran University
Start Date
2024-02-01
Trial ID
NCT06196502
Treatments Being Tested
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871741
Treatments Being Tested
The purpose of this study is to determine the durability of seroprotection ...
Status
Completed
Location
Clinical Research Associates of Tidewater
Start Date
2010-12
Trial ID
NCT01282762
This study is a cross-sectional study. The study aims to determine the leve...
Status
Completed
Location
Narongkorn Saiphoklang
Start Date
2025-04-01
Trial ID
NCT06901362
This is a randomized cross-sectional study of the Swedish population. Blood...
Status
Unknown
Location
Swedish Institute for Infectious Disease Control
Start Date
2007-03
Trial ID
NCT00932269
The primary purpose of this study is to determine whether HepavaxGene TF is...
Status
Completed
Location
Center for Disease Control and Prevention Jiangsu Province
Start Date
2011-05
Trial ID
NCT01349283
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested